Burning Rock Biotech Ltd
NASDAQ:BNR
Burning Rock Biotech Ltd
Total Equity
Burning Rock Biotech Ltd
Total Equity Peer Comparison
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
Total Equity
¥768.4m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Total Equity
¥25.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Total Equity
¥12.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Total Equity
¥12.7B
|
CAGR 3-Years
71%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Total Equity
¥31.5B
|
CAGR 3-Years
51%
|
CAGR 5-Years
46%
|
CAGR 10-Years
29%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Total Equity
¥5.8B
|
CAGR 3-Years
107%
|
CAGR 5-Years
78%
|
CAGR 10-Years
N/A
|
See Also
What is Burning Rock Biotech Ltd's Total Equity?
Total Equity
768.4m
CNY
Based on the financial report for Dec 31, 2023, Burning Rock Biotech Ltd's Total Equity amounts to 768.4m CNY.
What is Burning Rock Biotech Ltd's Total Equity growth rate?
Total Equity CAGR 3Y
-32%
Over the last year, the Total Equity growth was -34%. The average annual Total Equity growth rates for Burning Rock Biotech Ltd have been -32% over the past three years .